Tirzepatide vs Semaglutide vs Retatrutide: GLP-1 Peptide Comparison for Metabolic Research
TL;DR: Tirzepatide (a dual GIP/GLP-1 receptor agonist), semaglutide (a selective GLP-1 receptor agonist), and retatrutide (a triple agonist targeting GIP, GLP-1, and glucagon receptors) represent three generations of incretin-based peptides transforming metabolic disease research. This article…


